Creo Medical Group Statistics
Total Valuation
Creo Medical Group has a market cap or net worth of GBP 101.14 million. The enterprise value is 90.94 million.
Market Cap | 101.14M |
Enterprise Value | 90.94M |
Important Dates
The last earnings date was Monday, September 9, 2024.
Earnings Date | Sep 9, 2024 |
Ex-Dividend Date | n/a |
Share Statistics
Creo Medical Group has 351.78 million shares outstanding. The number of shares has increased by 72.61% in one year.
Shares Outstanding | 351.78M |
Shares Change (YoY) | +72.61% |
Shares Change (QoQ) | +34.91% |
Owned by Insiders (%) | 4.64% |
Owned by Institutions (%) | 74.19% |
Float | 315.22M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | 2.92 |
PB Ratio | 1.69 |
P/FCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
EV / Earnings | -4.19 |
EV / Sales | 2.95 |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | -3.99 |
Financial Position
The company has a current ratio of 3.83, with a Debt / Equity ratio of 13.88.
Current Ratio | 3.83 |
Quick Ratio | 2.94 |
Debt / Equity | 13.88 |
Debt / EBITDA | n/a |
Debt / FCF | -0.36 |
Interest Coverage | -62.00 |
Financial Efficiency
Return on equity (ROE) is -39.78% and return on invested capital (ROIC) is -24.01%.
Return on Equity (ROE) | -39.78% |
Return on Assets (ROA) | -20.42% |
Return on Capital (ROIC) | -24.01% |
Revenue Per Employee | 107,317 |
Profits Per Employee | -75,610 |
Employee Count | 287 |
Asset Turnover | 0.41 |
Inventory Turnover | 1.78 |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -11.54% in the last 52 weeks.
Beta (5Y) | n/a |
52-Week Price Change | -11.54% |
50-Day Moving Average | 30.34 |
200-Day Moving Average | 34.91 |
Relative Strength Index (RSI) | 41.76 |
Average Volume (20 Days) | 391,021 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Creo Medical Group had revenue of GBP 30.80 million and -21.70 million in losses. Loss per share was -0.07.
Revenue | 30.80M |
Gross Profit | 15.30M |
Operating Income | -24.80M |
Pretax Income | -24.50M |
Net Income | -21.70M |
EBITDA | -22.20M |
EBIT | -24.80M |
Loss Per Share | -0.07 |
Balance Sheet
The company has 18.50 million in cash and 8.30 million in debt, giving a net cash position of 10.20 million or 0.03 per share.
Cash & Cash Equivalents | 18.50M |
Total Debt | 8.30M |
Net Cash | 10.20M |
Net Cash Per Share | 0.03 |
Equity (Book Value) | 59.80M |
Book Value Per Share | 0.17 |
Working Capital | 28.00M |
Cash Flow
In the last 12 months, operating cash flow was -21.60 million and capital expenditures -1.20 million, giving a free cash flow of -22.80 million.
Operating Cash Flow | -21.60M |
Capital Expenditures | -1.20M |
Free Cash Flow | -22.80M |
FCF Per Share | -0.06 |
Margins
Gross margin is 49.68%, with operating and profit margins of -80.52% and -70.45%.
Gross Margin | 49.68% |
Operating Margin | -80.52% |
Pretax Margin | -79.55% |
Profit Margin | -70.45% |
EBITDA Margin | -72.08% |
EBIT Margin | -80.52% |
FCF Margin | -74.03% |
Dividends & Yields
Creo Medical Group does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -72.61% |
Shareholder Yield | -72.61% |
Earnings Yield | -24.11% |
FCF Yield | -22.54% |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |